- Home
- HGBL vs ANL Comparison
HGBL vs ANL Comparison
Compare HGBL & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGBL
- ANL
- Stock Information
- Founded
- HGBL 1937
- ANL 2004
- Country
- HGBL United States
- ANL Cayman Islands
- Employees
- HGBL N/A
- ANL N/A
- Industry
- HGBL Business Services
- ANL
- Sector
- HGBL Consumer Discretionary
- ANL
- Exchange
- HGBL Nasdaq
- ANL Nasdaq
- Market Cap
- HGBL 75.5M
- ANL 73.8M
- IPO Year
- HGBL N/A
- ANL 2023
- Fundamental
- Price
- HGBL $2.18
- ANL $1.47
- Analyst Decision
- HGBL Strong Buy
- ANL Buy
- Analyst Count
- HGBL 1
- ANL 2
- Target Price
- HGBL $4.00
- ANL N/A
- AVG Volume (30 Days)
- HGBL 68.8K
- ANL 14.8K
- Earning Date
- HGBL 08-07-2025
- ANL 08-08-2025
- Dividend Yield
- HGBL N/A
- ANL N/A
- EPS Growth
- HGBL N/A
- ANL N/A
- EPS
- HGBL 0.12
- ANL N/A
- Revenue
- HGBL $46,659,000.00
- ANL N/A
- Revenue This Year
- HGBL $12.86
- ANL N/A
- Revenue Next Year
- HGBL $7.02
- ANL N/A
- P/E Ratio
- HGBL $18.19
- ANL N/A
- Revenue Growth
- HGBL N/A
- ANL N/A
- 52 Week Low
- HGBL $1.52
- ANL $1.10
- 52 Week High
- HGBL $2.74
- ANL $4.10
- Technical
- Relative Strength Index (RSI)
- HGBL 59.46
- ANL 37.32
- Support Level
- HGBL $1.97
- ANL $1.56
- Resistance Level
- HGBL $2.10
- ANL $1.74
- Average True Range (ATR)
- HGBL 0.09
- ANL 0.15
- MACD
- HGBL 0.01
- ANL -0.01
- Stochastic Oscillator
- HGBL 75.00
- ANL 12.50
About HGBL Heritage Global Inc.
Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.